High drug prices due to unreasonable margins of companies: CCI - 25.10.2018

Competition Commission of India (CCI) has said in a policy note on affordable healthcare that Unreasonably high trade margins of drug companies are the primary cause of high drug prices in India.

Tags : CCI Drug Prices

Share :